Literature DB >> 6209890

Drug eruptions: causative agents and clinical types. A series of in-patients during a 10-year period.

K Kauppinen, S Stubb.   

Abstract

A series of 446 inpatients with drug eruption was studied to determine the causative agent and the clinical type. In over a half of the cases a provocation test confirmed the drug responsible for the reaction. Sulphonamides/trimethoprim and ampicillin/penicillin followed by phenazones were the most frequent agents causing eruptions. Sulphonamides were also the most common drugs inducing Lyell's and Stevens-Johnson syndromes. Phenazones and barbiturates were the main causes of fixed eruptions. The frequency of inpatients having drug eruption was decreased in the 1971-80 series compared with the earlier one from 1961-70. Also the frequency of Lyell's and Stevens-Johnson syndromes was lower in the latter decade than in the earlier one.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209890

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

Review 1.  Drug eruptions.

Authors:  S K Goolamali
Journal:  Postgrad Med J       Date:  1985-10       Impact factor: 2.401

2.  Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India.

Authors:  Kikkeri Narayanasetty Naveen; Varadraj V Pai; Vijetha Rai; Sharatchandra B Athanikar
Journal:  Indian J Pharmacol       Date:  2013 Jan-Feb       Impact factor: 1.200

3.  Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey.

Authors:  Fatma Akpinar; Emine Dervis
Journal:  Indian J Dermatol       Date:  2012-05       Impact factor: 1.494

4.  Adverse cutaneous drug reaction.

Authors:  Surajit Nayak; Basanti Acharjya
Journal:  Indian J Dermatol       Date:  2008-01       Impact factor: 1.494

5.  Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective.

Authors:  Ruchika Nandha; Anita Gupta; Arif Hashmi
Journal:  Int J Appl Basic Med Res       Date:  2011-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.